Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,700 | 2 | 86.5% |
| Food and Beverage | $335.30 | 13 | 10.7% |
| Education | $85.00 | 1 | 2.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PIRAMAL CRITICAL CARE | $2,789 | 4 | $0 (2024) |
| ABBVIE INC. | $156.95 | 7 | $0 (2024) |
| Merz Pharmaceuticals, LLC | $129.82 | 2 | $0 (2023) |
| UCB, Inc. | $30.22 | 2 | $0 (2017) |
| Allergan, Inc. | $14.81 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,822 | 5 | PIRAMAL CRITICAL CARE ($2,789) |
| 2023 | $203.02 | 5 | Merz Pharmaceuticals, LLC ($129.82) |
| 2022 | $65.12 | 4 | ABBVIE INC. ($50.31) |
| 2017 | $30.22 | 2 | UCB, Inc. ($30.22) |
All Payment Transactions
16 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/02/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $33.44 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 06/25/2024 | PIRAMAL CRITICAL CARE | GABLOFEN (Drug), GABLOFEN, GABLOFEN | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,400.00 | General |
| Category: Pharmacology | ||||||
| 06/20/2024 | PIRAMAL CRITICAL CARE | GABLOFEN (Drug), GABLOFEN, GABLOFEN | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Pharmacology | ||||||
| 05/21/2024 | PIRAMAL CRITICAL CARE | GABLOFEN (Drug), GABLOFEN, GABLOFEN | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $300.00 | General |
| Category: Pharmacology | ||||||
| 02/22/2024 | PIRAMAL CRITICAL CARE | GABLOFEN (Drug), GABLOFEN, GABLOFEN | Food and Beverage | In-kind items and services | $72.60 | General |
| Category: Pharmacology | ||||||
| 10/04/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $25.96 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 05/04/2023 | Merz Pharmaceuticals, LLC | — | Education | In-kind items and services | $85.00 | General |
| 04/17/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 02/22/2023 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $44.82 | General |
| Category: Musculoskeletal | ||||||
| 01/18/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $27.71 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/02/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $12.58 | General |
| Category: HYPERHYDROSIS | ||||||
| 06/08/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: HYPERHYDROSIS | ||||||
| 04/22/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: HYPERHYDROSIS | ||||||
| 03/31/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: HYPERHYDROSIS | ||||||
| 03/03/2017 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $28.43 | General |
| Category: Neurology | ||||||
| 03/03/2017 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $1.79 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 185 | 269 | $62,912 | $17,384 |
| 2022 | 6 | 158 | 250 | $63,905 | $17,220 |
| 2021 | 6 | 170 | 257 | $68,765 | $20,219 |
| 2020 | 6 | 196 | 273 | $72,585 | $20,092 |
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 41 | 67 | $14,405 | $4,297 | 29.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 26 | 36 | $11,520 | $3,364 | 29.2% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 29 | 56 | $7,000 | $2,251 | 32.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 32 | 37 | $7,955 | $2,083 | 26.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $7,760 | $2,050 | 26.4% |
| 64642 | Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity | Facility | 2023 | 14 | 20 | $6,600 | $1,427 | 21.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 13 | 13 | $5,200 | $1,371 | 26.4% |
| 76942 | Ultrasonic guidance for needle placement | Facility | 2023 | 14 | 24 | $2,472 | $541.20 | 21.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 43 | 91 | $19,565 | $5,257 | 26.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 38 | 49 | $15,680 | $4,520 | 28.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 22 | 22 | $10,670 | $2,831 | 26.5% |
| 64642 | Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity | Facility | 2022 | 15 | 26 | $8,580 | $2,108 | 24.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 22 | 27 | $5,805 | $1,666 | 28.7% |
| 76942 | Ultrasonic guidance for needle placement | Facility | 2022 | 18 | 35 | $3,605 | $838.19 | 23.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 56 | 115 | $24,725 | $6,899 | 27.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 39 | 57 | $12,255 | $4,046 | 33.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 29 | 38 | $12,160 | $3,598 | 29.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 21 | 21 | $10,185 | $2,994 | 29.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 13 | 14 | $5,600 | $1,589 | 28.4% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 12 | 12 | $3,840 | $1,093 | 28.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 54 | 120 | $25,800 | $7,340 | 28.5% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2020 | 60 | 66 | $19,470 | $5,607 | 28.8% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 34 | 34 | $16,490 | $4,273 | 25.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 18 | 22 | $4,730 | $1,243 | 26.3% |
| G0425 | Telehealth consultation, emergency department or initial inpatient, typically 30 minutes communicating with the patient via telehealth | Facility | 2020 | 12 | 12 | $3,720 | $1,004 | 27.0% |
About Dr. Samuel Lee, MD
Dr. Samuel Lee, MD is a Physical Medicine & Rehabilitation healthcare provider based in Ventura, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/24/2011. The National Provider Identifier (NPI) number assigned to this provider is 1871892133.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Samuel Lee, MD has received a total of $3,120 in payments from pharmaceutical and medical device companies, with $2,822 received in 2024. These payments were reported across 16 transactions from 5 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($2,700).
As a Medicare-enrolled provider, Lee has provided services to 709 Medicare beneficiaries, totaling 1,049 services with total Medicare billing of $74,915. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Location Ventura, CA
- Active Since 03/24/2011
- Last Updated 09/17/2015
- Taxonomy Code 208100000X
- Entity Type Individual
- NPI Number 1871892133
Products in Payments
- GABLOFEN (Drug) $2,789
- BOTOX (Biological) $171.76
- Xeomin (Biological) $44.82
- Briviact (Drug) $30.22
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physical Medicine & Rehabilitation Doctors in Ventura
Dr. Matthew Bloom, Do, DO
Physical Medicine & Rehabilitation — Payments: $15,589
Phillip Nguyen, Md, MD
Physical Medicine & Rehabilitation — Payments: $6,607
Eric Watson, D.o, D.O
Physical Medicine & Rehabilitation — Payments: $1,202
Ellen Cantos, Pt, PT
Physical Medicine & Rehabilitation
Mrs. Benjamine Sagar, Pt Bcb-Pmd, PT BCB-PMD
Physical Medicine & Rehabilitation
Ma Rowena Castillo, Dpt, DPT
Physical Medicine & Rehabilitation